Sunday, September 29, 2019

Google Alert - technology

Google
technology
As-it-happens update September 29, 2019
NEWS
Attack of the Fanboy
In Ghost Recon Breakpoint using a silencer allows you to engage enemies without alerting everyone around you. The silencer in Ghost Recon Breakpoint will be equipped automatically when you start the game, but you can add and remove the silencer at ...
Facebook Twitter Flag as irrelevant
News18
Gaming smartphones have become quite popular, thanks to the PUBG Mobile craze and if you love earning that glorious chicken dinner, then you need solid hardware. Flipkart's Big Billion Days sale is here, bringing some worthy deals on the top gaming ...
Facebook Twitter Flag as irrelevant
News18
With the arrival of OnePlus 7T, we were expecting the company to lower the price of the OnePlus 7 Pro as well as the OnePlus 7. Well, the company isn't holding back and is now selling both the handsets at a reduced price during the Amazon Great Indian ...
Facebook Twitter Flag as irrelevant
Telegraph.co.uk
Science fiction films often depict the fear that one day, robots will seize power over humanity. Now machines have started appearing in workplaces in Britain, it appears humans have started the fightback. A new study by De Montfort University in Leicester has ...
Facebook Twitter Flag as irrelevant
Telegraph.co.uk
UK-style plans for a unilateral digital services tax on big tech companies are doomed to fail, Google chief executive Sundar Pichai has claimed. In an interview at the tech giant's California headquarters, Mr Pichai said plans by individual nations to act alone by ...
Facebook Twitter Flag as irrelevant
PCGamesN
Project Resistance was revealed by Capcom earlier this month, and the gaming world remains a little divided over it – or ambivalent, at worst. On one hand, it's a brand new Resident Evil game using the RE2 remake's game engine, and an interesting concept ...
Facebook Twitter Flag as irrelevant
The Lancet
The addition of Erleada to androgen deprivation therapy (ADT) reduced the risk for death by 25% compared with placebo in patients with nonmetastatic castration-resistant prostate cancer, according to updated findings of the phase 3 SPARTAN trial that were ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

No comments:

Post a Comment